Tratamiento del deseo sexual hipoactivo de la mujer

Masters, 1966 Kaplan, 1979 Schnarch, 1991 Basson, 2002, Women's sexual desire–disordered or misunderstood?, J Sex Marital Ther, 28, 17, 10.1080/00926230252851168 Cawood, 1996, Steroid hormones, menopause, sexuality and well-being of woman, Physicol Physiol Med, 26, 925 Levin, 2002, The physiology of sexual arousal in the human female: a recreational and procreational synthesis, Arch Sex Behav, 31, 401, 10.1023/A:1019836007416 Fisher, 2002, Defining the brain systems of lust, romantic, attraction and attachment, Arch Sex Behav, 31, 413, 10.1023/A:1019888024255 2000 Basson, 2003, Definitions of women sexual dysfunction reconsidered: advocating expansion and revision, J Psychosom Obstet Gynecol, 24, 221, 10.3109/01674820309074686 Fuertes, 1995, La naturaleza del deseo sexual y sus problemas: Implicaciones terapéuticas, Cuadernos de Medicina Psicosomática, 33, 28 Cabello-Santamaría, 2007, Estado actual del tratamiento farmacológico del deseo sexual hipoactivo de la mujer, Sexología Integral, 4 L’Abate, 1983 Burnett, 1997, Immunohistochemtical description of nitric oxide synthase isoforms in human clitoris, J Urol, 158, 75, 10.1097/00005392-199707000-00020 Hoyle, 1996, Innervation of vasculature and microvasculature of the human vagina by NOS and neuropeptide-containing nerves, Am J Anat, 188, 633 Park, 1998, Sildenafil inhibits phosphodiesterase type 5 in human clitoral corpus cavernosum smooth muscle, Biochem Biophys Res Commun, 249, 612, 10.1006/bbrc.1998.9206 Caruso, 2001, Premenopausal women affected by sexual arousal disorder treated with sildenafilo: a double-blind, cross-over, placebo-controlled study, BJOG, 108, 623, 10.1016/S0306-5456(00)00143-1 Basson, 2002, Efficacy and safety of sildenafilo citrate in women with sexual dysfunction associated with female sexual arousal disorder, J Womens Health Gend Based Med, 11, 367, 10.1089/152460902317586001 Basson, 2003, Sexual psychophysiology and effects of sildenafilo citrate in oestrogenised women with acquired genital arousal disorder and impaired orgasm: a randomised controlled trial, BJOG, 110, 1014, 10.1111/j.1471-0528.2003.02438.x Berman, 2003, Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double-blind, placebo controlled study, J Urol, 170, 2333, 10.1097/01.ju.0000090966.74607.34 Cabello-Santamaría, 2005, El futuro incierto de la investigación en sexualidad femenina, Sexología Integral, 2, 12 Greenbaltt, 1950, Evaluation of an estrogen, androgen, estrogen-androgen combination and a placebo in the treatment of the menopause, J Clin Endocrinol, 10, 1547, 10.1210/jcem-10-12-1547 Zumoff, 1995, Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women, J Clin Endocrinol Metab, 80, 1429, 10.1210/jc.80.4.1429 Goldstat, 2003, Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women, Menopause, 10, 390, 10.1097/01.GME.0000060256.03945.20 Braunstein, 2002, Androgen insufficiency in women: summary of critical issues, Fertil Steril, 77, S94, 10.1016/S0015-0282(02)02962-X Documentos de Consenso de la SEGO. Madrid: SEGO; 2005. p. 41-111. Simon, 2005, Testosterone patch increases sexual activity and desire in surgically menopausal women with hipoactive sexual desire disorder, J Clin Endocrinol Metab, 90, 5226, 10.1210/jc.2004-1747 Buster, 2005, Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial, Obstet Gynecol, 105, 944, 10.1097/01.AOG.0000158103.27672.0d Nyunt, 2005, Androgen status in healthy premenopausal women with loss of libido, J Sex Marital Ther, 1, 73, 10.1080/00926230590475314 Conaglen, 2003, Sexual desire in women presenting for antiandrogen therapy, J Sex Marital Ther, 4, 255, 10.1080/00926230390195498 Sherwin, 1987, A prospective one-year study of strogen and progestin in postmenopausal women: effects on cliniclal syntoms and lipoprotein lipid, Psychosom Med, 49, 397, 10.1097/00006842-198707000-00009 Lobo, 2003, Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire, Fertile Steril, 79, 1341, 10.1016/S0015-0282(03)00358-3 Arlt, 1998, Oral DHEA replacement, J Clin Endocrinol Metab, 83, 1928, 10.1210/jc.83.6.1928 Meston, 2002, Acute dehydroepiandrosterone effects on sexual arousal in premenopausal women, J Sex Marital Ther, 28, 53, 10.1080/009262302317251016 Arlt, 2003, Management of the androgen-deficient woman, Growth Horm IGF Res, 13, S85, 10.1016/S1096-6374(03)00060-1 Leo, 1986, Curr Ther Res, 40, 124 Boyarsky, 1999, Sexual functioning in depressed outpatients taking mirtazapina, Depress Anxiety, 9, 175, 10.1002/(SICI)1520-6394(1999)9:4<175::AID-DA5>3.0.CO;2-0 Segraves, 2004, Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women, J Clin Psychol, 24, 339 Segraves, 2001, Bupropion sustained release (SR) for the treatment of hypoactive sexual desire disorder (HSDD) in nondepressed women, J Sex Marital Ther, 27, 303, 10.1080/009262301750257155 Clayton, 2004, A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor- induced sexual dysfunction, J Clin Psychiatry, 65, 62, 10.4088/JCP.v65n0110 Cabello-Santamaría F. Effectiveness of the treatment with bupropion, sexual therapy and bupropion combined with sexual therapy in the treatment of woman's hypoactive sexual desire disorder. En: XVII World Congress of Sexology. Montreal; Julio de 2005. D’Aquila, 1997, Antianhedonic actions of the novel serotonergic agent flibanserin, a potential rapidly-acting antidepressant, Eur J Pharmacol, 340, 121, 10.1016/S0014-2999(97)01412-X Wang, 2006, Lasofoxifene enhances vaginal mucus formation without causing hypertrophy and increases estrogen receptor beta and androgen receptor in rats, Menopause, 13, 609, 10.1097/01.gme.0000227337.73738.c9 Kovalevsky, 2005, Female sexual dysfunction and use of hormone therapy in postmenopausal women, Semin Reprod Med, 23, 180, 10.1055/s-2005-869486 Diamond, 2006, An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist, J Sex Med, 3, 628, 10.1111/j.1743-6109.2006.00268.x McCarthy, 1984, Strategies and techniques for the treatment of inhibited sexual desire, J Sex Marital Ther, 10, 97, 10.1080/00926238408405795 McCarthy, 1992, J Sex Educ Ther, 18, 22, 10.1080/01614576.1992.11074036 McCarthy, 1995, Bridges to sexual desire, J Sex Educ Ther, 21, 132, 10.1080/01614576.1995.11074144 LoPiccolo, 1998, Broad-spectrum treatment of low sexual desire Trudel, 1996, Hypoactive sexual desire in couples: a cognitive-behavioral perspective Trudel, 1997, Low sexual desire: the role of anxiety, depression and marital adjustment, Sexual and Marital Therapy, 12, 109, 10.1080/02674659708408204 Trudel, 2001, The effect of a cognitive-behavioral group treatment program on hypoactive sexual desire in women, Sex Rel Ther, 16, 10.1080/14681990120040078 Maletzky, 1995, Orgasmic reconditioning Regas, 1984, Functional family therapy and treatment of inhibited sexual desire, J Marital Family Ther, 10, 63, 10.1111/j.1752-0606.1984.tb00566.x Verhulst, 1988, A systems perspective on sexual desire